Regeneron Pharmaceuticals (REGN) announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD or ...
Finding the perfect gift can be a challenge, especially as time runs out. That’s why we’ve rounded up thoughtful and unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback